scispace - formally typeset
H

Hyewon Park

Researcher at Yonsei University

Publications -  32
Citations -  956

Hyewon Park is an academic researcher from Yonsei University. The author has contributed to research in topics: Microvesicles & QT interval. The author has an hindex of 11, co-authored 32 publications receiving 743 citations. Previous affiliations of Hyewon Park include Ewha Womans University & Kansas State University.

Papers
More filters
Journal ArticleDOI

Self-Powered Cardiac Pacemaker Enabled by Flexible Single Crystalline PMN-PT Piezoelectric Energy Harvester

TL;DR: A flexible single-crystalline PMN-PT piezoelectric energy harvester is demonstrated to achieve a self-powered artificial cardiac pacemaker that meets the standard for charging commercial batteries but also for stimulating the heart without an external power source.
Journal ArticleDOI

Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes.

TL;DR: Genetic modification of exosomes by expressing CTP-Lamp2b on the exosomal membrane enhanced exosome delivery to heart cells and the heart tissue without toxicity and suggested that C TP-Exo might be used as a therapeutic tool for heart disease.
Journal ArticleDOI

Extracellular Vesicles Derived from Hypoxic Human Mesenchymal Stem Cells Attenuate GSK3β Expression via miRNA-26a in an Ischemia-Reperfusion Injury Model

TL;DR: Findings suggest that the beneficial effect of EVHM is related with Wnt signaling pathway, and this study investigated the mechanism of the cardioprotective effects of EVs derived from hypoxia-preconditioned human mesenchymal stem cells (MSCs).
Journal ArticleDOI

Human peripheral blood‑derived exosomes for microRNA delivery.

TL;DR: Results suggested that miRNA-loaded human peripheral blood derived-exosomes may be used as a therapeutic tool for cardiac diseases.
Journal ArticleDOI

Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation.

TL;DR: Findings suggest that serum exosomal miRNAs might be used as novel biomarkers to reflect the progression of AF and may allow their use as candidate biomarkers.